MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>

To explore whether combined treatments with daptomycin and gentamicin can prevent the development of <i>Staphylococcus aureus</i> resistance, and whether the possible restriction is associated with changes in antibiotic mutant prevention concentrations (MPCs), the enrichment of daptomyci...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria V. Golikova (Author), Elena N. Strukova (Author), Yury A. Portnoy (Author), Stephen H. Zinner (Author), Alexander A. Firsov (Author)
Format: Book
Published: MDPI AG, 2021-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8cde7af0099b4a75a84e1c1012db1140
042 |a dc 
100 1 0 |a Maria V. Golikova  |e author 
700 1 0 |a Elena N. Strukova  |e author 
700 1 0 |a Yury A. Portnoy  |e author 
700 1 0 |a Stephen H. Zinner  |e author 
700 1 0 |a Alexander A. Firsov  |e author 
245 0 0 |a MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i> 
260 |b MDPI AG,   |c 2021-09-01T00:00:00Z. 
500 |a 10.3390/antibiotics10101148 
500 |a 2079-6382 
520 |a To explore whether combined treatments with daptomycin and gentamicin can prevent the development of <i>Staphylococcus aureus</i> resistance, and whether the possible restriction is associated with changes in antibiotic mutant prevention concentrations (MPCs), the enrichment of daptomycin- and gentamicin-resistant mutants was studied by simulating 5-day single and combined treatments in an in vitro dynamic model. The MPCs of the antibiotics in the combination were determined at concentration ratios equal to the ratios of 24 h areas, under the concentration-time curve (AUCs) of the antibiotics, as simulated in pharmacodynamic experiments. The MPCs of both daptomycin and gentamicin decreased in the presence of each other; this led to an increase in the time when antibiotic concentrations were above the MPC (<i>T</i><sub>>MPC</sub>). The increases in <i>T</i><sub>>MPC</sub>s were concurrent with increases of the anti-mutant effects of the combined antibiotics. When anti-mutant effects of the antibiotics in single and combined treatments were plotted against the <i>T</i><sub>>MPC</sub>s, significant sigmoid relationships were obtained. These findings suggest that (1) daptomycin-gentamicin combinations prevent the development of <i>S. aureus</i> resistance to each antibiotic; (2) the anti-mutant effects of antibiotic combinations can be predicted using MPCs determined at pharmacokinetic-based antibiotic concentration ratios; (3) <i>T</i><sub>>MPC</sub> is a reliable predictor of the anti-mutant efficacy of antibiotic combinations. 
546 |a EN 
690 |a daptomycin-gentamicin combination 
690 |a in vitro model 
690 |a anti-mutant effect 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 10, Iss 10, p 1148 (2021) 
787 0 |n https://www.mdpi.com/2079-6382/10/10/1148 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/8cde7af0099b4a75a84e1c1012db1140  |z Connect to this object online.